Meeting Banner
Abstract #3921

Ferumoxytol Enhanced 2D & 3D Phase Contrast MRI in Dialysis Fistulas

Monica Sigovan1, Gabriel Acevedo-Bolton1, Petter Dyverfeldt1, Christopher Owens2, David Saloner1

1Radiology, UCSF, San Francisco, CA, United States; 2Vascular Surgery, UCSF, San Francisco, CA, United States

Ferumoxytol is a very promising MRI contrast agent for medical applications in which Gadolinium agents are contra-indicated. The quality of Phase Contrast MR acquisitions can be improved with the use of Gd. In comparison, Ferumoxytols higher r2* relaxivity could potentially induce strong intravoxel dephasing leading to errors in flow measurements. The objective was to evaluate ferumoxytols effect on 2D and 3D PC-MR flow imaging by simulations, In Vitro and in vivo imaging.

Abstract PDF E-Poster Video

Keywords

administration affect agent anemia applications arterial artery blood bottom characteristics circulating concentration concentrations considered cont contrast corrected dependent dialysis dominant done dose eddy errors essential evaluate every experience experiment extremity fast field fistula fistulas flow function furthermore gadolinium general greatly highly important improved in vivo included increasing indicator induce intensities iron know laminar linear location loop measured medical moving objective oxide patients petter phantom pixel plots post product proved pulses radiology reach recently relatively saline sealed simulated simulation spins spoiled static steady streamline subtracting surround table theoretical tissue treatment trends tube unction undergo variation vary vascular vein velocity venous vessels visualization vitro water wing